Обзорная статья

microRNAs: New prognostic, diagnostic, and therapeutic biomarkers in cervical cancer

Javid Sadri NahandDepartment of Virology Student Research Committee, Faculty of Medicine, Iran University of Medical Sciences Tehran IranSima Taghizadeh‐boroujeniBlood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine Brujen IranMohammad Reza KarimzadehDepartment of Virology Student Research Committee, Faculty of Medicine, Iran University of Medical Sciences Tehran IranSarina BorranSchool of Medicine, Shahid Beheshti University of Medical Sciences Tehran IranMohammad Hossein PourhanifehResearch Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences Kashan IranMohsen MoghoofeiDepartment of Microbiology Faculty of Medicine, Kermanshah University of Medical Sciences Kermanshah IranFarah Bokharaei‐SalimDepartment of Virology Student Research Committee, Faculty of Medicine, Iran University of Medical Sciences Tehran IranSajad KarampoorDepartment of Virology Student Research Committee, Faculty of Medicine, Iran University of Medical Sciences Tehran IranAmir JafariDepartment of Medical Nanotechnology Faculty of Advanced Technology in Medicine, Iran University of Medical Sciences Tehran IranZatollah AsemiResearch Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences Kashan IranAlireza TbibzadehDepartment of Virology Student Research Committee, Faculty of Medicine, Iran University of Medical Sciences Tehran IranAfshin NamdarDepartment of Dentistry Faculty of Medicine and Dentistry, University of Alberta Edmonton CanadaHamed MirzaeiResearch Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences Kashan Iran

2019en

ABI

Аннотация

Cervical cancer is as a kind of cancer beginning from the cervix. Given that cervical cancer could be observed in women who infected with papillomavirus, regular oral contraceptives, and multiple pregnancies. Early detection of cervical cancer is one of the most important aspects of the therapy of this malignancy. Despite several efforts, finding and developing new biomarkers for cervical cancer diagnosis are required. Among various prognostic, diagnostic, and therapeutic biomarkers, miRNA have been emerged as powerful biomarkers for detection, treatment, and monitoring of response to therapy in cervical cancer. Here, we summarized various miRNAs as an employable platform for prognostic, diagnostic, and therapeutic biomarkers in the treatment of cervical cancer.

Перевод пока недоступен

Идентификаторы

DOI: 10.1002/jcp.28457

Цитирования и источники

Цитирований: 5Использованных источников: 0

Показатели — AkademScholar